Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation Appointed director
|
Verrica Pharmaceuticals Inc. (VRCA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
11/07/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
05/09/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
08/10/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
05/07/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
11/09/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
08/05/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
05/07/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
11/06/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
08/07/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
05/07/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
11/07/2018 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
08/07/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
|
|